Video

Roundtable - Impact of API Globalisation on Drug Shortages

Watch Video

Roundtable - Impact of API Globalisation on Drug Shortages

This Roundtable will feature a high-level panel discussion from industry experts, with numerous opportunities for audience interaction – polls, Q&A and break-out networking sessions. A great opportunity to deep-dive into specific topics, discuss opinions and gather insights from the wider pharma community. Good quality Active Pharmaceutical Ingredients (API) are core to the manufacturing of effective and safe essential drugs. Only a limited number of large manufacturers of finished pharmaceutical products have their own API manufacturing capabilities, and very few have the capacity to manufacture all the required APIs in-house - meaning many rely on foreign sources. As an essential part of the pharmaceutical value chain, API producers are actively looking for solutions that can address the root causes of this issue and set a contingency plan. However, the COVID-19 outbreak has revived fears over acute drug shortages in several countries, sparking calls to repatriate the production of pharmaceutical ingredients to home soil. • Strategies, proactive and structural actions to prevent further drug shortages • The role of the growing globalization of the API pharmaceutical market and safeguard of the pharmaceutical Supply Chain in a Global Economy • Incentives and Challenges to increase local production of drugs and API • Competitiveness of the market, assessing the risk that manufacturers or traders in monopolizing parts of the API market • EU APIs supply chain: overview and consideration for the future

Aired as part of the CPhI Festival of pharma